Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Management
Volume 2017, Article ID 8296501, 12 pages
https://doi.org/10.1155/2017/8296501
Review Article

Amygdala Plasticity and Pain

1Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX, USA
2Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX, USA

Correspondence should be addressed to Volker Neugebauer; ude.cshutt@reuabeguen.reklov

Received 20 July 2017; Accepted 2 November 2017; Published 10 December 2017

Academic Editor: Susanne Becker

Copyright © 2017 Jeremy M. Thompson and Volker Neugebauer. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. H. Janak and K. M. Tye, “From circuits to behaviour in the amygdala,” Nature, vol. 517, no. 7534, pp. 284–292, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Marek, C. Strobel, T. W. Bredy, and P. Sah, “The amygdala and medial prefrontal cortex: partners in the fear circuit,” Journal of Physiology, vol. 591, no. 10, pp. 2381–2391, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. H. C. Pape and D. Pare, “Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear,” Physiological Reviews, vol. 90, no. 2, pp. 419–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. E. A. Phelps and J. E. LeDoux, “Contributions of the amygdala to emotion processing: from animal models to human behavior,” Neuron, vol. 48, no. 2, pp. 175–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. V. Apkarian, V. Neugebauer, G. Koob et al., “Neural mechanisms of pain and alcohol dependence,” Pharmacology Biochemistry and Behavior, vol. 112, pp. 34–41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. C. Bushnell, M. Ceko, and L. A. Low, “Cognitive and emotional control of pain and its disruption in chronic pain,” Nature Reviews Neuroscience, vol. 14, no. 7, pp. 502–511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Neugebauer, “Amygdala pain mechanisms,” Handbook of Experimental Pharmacology, vol. 227, pp. 261–284, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Neugebauer, V. Galhardo, S. Maione, and S. C. Mackey, “Forebrain pain mechanisms,” Brain Research Reviews, vol. 60, no. 1, pp. 226–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Neugebauer, W. Li, G. C. Bird, and J. S. Han, “The amygdala and persistent pain,” Neuroscientist, vol. 10, no. 3, pp. 221–234, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. L. E. Simons, E. A. Moulton, C. Linnman, E. Carpino, L. Becerra, and D. Borsook, “The human amygdala and pain: evidence from neuroimaging,” Human Brain Mapping, vol. 35, no. 2, pp. 527–538, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Vachon-Presseau, M. V. Centeno, W. Ren et al., “The emotional brain as a predictor and amplifier of chronic pain,” Journal of Dental Research, vol. 95, no. 6, pp. 605–612, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Veinante, I. Yalcin, and M. Barrot, “The amygdala between sensation and affect: a role in pain,” Journal of Molecular Psychiatry, vol. 1, no. 1, p. 9, 2013. View at Publisher · View at Google Scholar
  13. J. F. Bernard, M. Alden, and J.-M. Besson, “The organization of the efferent projections from the pontine parabrachial area to the amygdaloid complex: a Phaseolus vulgaris leucoagglutinin (PHA-L) study in the rat,” Journal of Comparative Neurology, vol. 329, no. 2, pp. 201–229, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Gauriau and J.-F. Bernard, “Pain pathways and parabrachial circuits in the rat,” Experimental Physiology, vol. 87, no. 2, pp. 251–258, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. N. Baliki and A. V. Apkarian, “Nociception, pain, negative moods, and behavior selection,” Neuron, vol. 87, no. 3, pp. 474–491, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Hebben, S. Corkin, H. Eichenbaum, and K. Shedlack, “Diminished ability to interpret and report internal states after bilateral medial temporal resection: case H.M.,” Behavioral Neuroscience, vol. 99, no. 6, pp. 1031–1039, 1985. View at Publisher · View at Google Scholar
  17. R. H. Dossani, S. Missios, and A. Nanda, “The legacy of Henry Molaison (1926–2008) and the impact of his bilateral mesial temporal lobe surgery on the study of human memory,” World Neurosurgery, vol. 84, no. 4, pp. 1127–1135, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Kulkarni, D. E. Bentley, R. Elliott et al., “Arthritic pain is processed in brain areas concerned with emotions and fear,” Arthritis and Rheumatism, vol. 56, no. 4, pp. 1345–1354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Tillisch, E. A. Mayer, and J. S. Labus, “Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome,” Gastroenterology, vol. 140, no. 1, pp. 91–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. F. Bernard, G. F. Huang, and J. M. Besson, “Nucleus centralis of the amygdala and the globus pallidus ventralis: electrophysiological evidence for an involvement in pain processes,” Journal of Neurophysiology, vol. 68, no. 2, pp. 551–569, 1992. View at Google Scholar
  21. V. Neugebauer and W. Li, “Processing of nociceptive mechanical and thermal information in central amygdala neurons with knee-joint input,” Journal of Neurophysiology, vol. 87, no. 1, pp. 103–112, 2002. View at Publisher · View at Google Scholar
  22. K. Bon, M. Lanteri-Minet, J. F. Michiels, and D. Menetrey, “Cyclophosphamide cystitis as a model of visceral pain in rats: a c-fos and Krox-24 study at telencephalic levels, with a note on pituitary adenylate cyclase activating polypeptide (PACAP),” Experimental Brain Research, vol. 122, no. 2, pp. 165–174, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. L. W. Crock, B. J. Kolber, C. D. Morgan et al., “Central amygdala metabotropic glutamate receptor 5 in the modulation of visceral pain,” Journal of Neuroscience, vol. 32, no. 41, pp. 14217–14226, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Greenwood-Van Meerveld, A. C. Johnson, J. Schulkin, and D. A. Myers, “Long-term expression of corticotropin-releasing factor (CRF) in the paraventricular nucleus of the hypothalamus in response to an acute colonic inflammation,” Brain Research, vol. 1071, no. 1, pp. 91–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. S. Han and V. Neugebauer, “Synaptic plasticity in the amygdala in a visceral pain model in rats,” Neuroscience Letters, vol. 361, no. 1–3, pp. 254–257, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Nishii, M. Nomura, H. Aono, N. Fujimoto, and T. Matsumoto, “Up-regulation of galanin and corticotropin-releasing hormone mRNAs in the key hypothalamic and amygdaloid nuclei in a mouse model of visceral pain,” Regulatory Peptides, vol. 141, no. 1–3, pp. 105–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. K. E. Sadler, N. A. McQuaid, A. C. Cox, M. N. Behun, A. M. Trouten, and B. J. Kolber, “Divergent functions of the left and right central amygdala in visceral nociception,” Pain, vol. 158, no. 4, pp. 747–759, 2017. View at Publisher · View at Google Scholar
  28. P. Suwanprathes, M. Ngu, A. Ing, G. Hunt, and F. Seow, “c-Fos immunoreactivity in the brain after esophageal acid stimulation,” American Journal of Medicine, vol. 115, no. 3, pp. 31S–38S, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. M. O. Adedoyin, S. Vicini, and J. H. Neale, “Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model,” Molecular Pain, vol. 6, p. 60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Carrasquillo and R. W. Gereau, “Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception,” Journal of Neuroscience, vol. 27, no. 7, pp. 1543–1551, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Carrasquillo and R. W. Gereau, “Hemispheric lateralization of a molecular signal for pain modulation in the amygdala,” Molecular Pain, vol. 4, p. 24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. J. Cheng, C.-C. Chen, H.-W. Yang et al., “Role of extracellular signal-regulated kinase in synaptic transmission and plasticity of a nociceptive input on capsular central amygdaloid neurons in normal and acid-induced muscle pain mice,” Journal of Neuroscience, vol. 31, no. 6, pp. 2258–2270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. G. C. Bird, L. L. Lash, J. S. Han, X. Zou, W. D. Willis, and V. Neugebauer, “Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones,” Journal of Physiology, vol. 564, no. 3, pp. 907–921, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Fu and V. Neugebauer, “Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior,” Journal of Neuroscience, vol. 28, no. 15, pp. 3861–3876, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. S. Han, W. Li, and V. Neugebauer, “Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior,” Journal of Neuroscience, vol. 25, no. 46, pp. 10717–10728, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Ji and V. Neugebauer, “Hemispheric lateralization of pain processing by amygdala neurons,” Journal of Neurophysiology, vol. 102, no. 4, pp. 2253–2264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Neugebauer and W. Li, “Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain,” Journal of Neurophysiology, vol. 89, no. 2, pp. 716–727, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Neugebauer, W. Li, G. C. Bird, G. Bhave, and R. W. Gereau, “Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5,” Journal of neuroscience, vol. 23, no. 1, pp. 52–63, 2003. View at Google Scholar
  39. W. Ren, T. Kiritoshi, S. Gregoire et al., “Neuropeptide S: a novel regulator of pain-related amygdala plasticity and behaviors,” Journal of Neurophysiology, vol. 110, no. 8, pp. 1765–1781, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Ren and V. Neugebauer, “Pain-related increase of excitatory transmission and decrease of inhibitory transmission in the central nucleus of the amygdala are mediated by mGluR1,” Molecular Pain, vol. 6, p. 93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Tappe-Theodor, Y. Fu, R. Kuner, and V. Neugebauer, “Homer1a signaling in the amygdala counteracts pain-related synaptic plasticity, mGluR1 function and pain behaviors,” Molecular Pain, vol. 7, p. 38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Goncalves and A. H. Dickenson, “Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation,” European Journal of Neuroscience, vol. 36, no. 9, pp. 3204–3213, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Ikeda, Y. Takahashi, K. Inoue, and F. Kato, “NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain,” Pain, vol. 127, no. 1, pp. 161–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Ji, W. Zhang, L. Mahimainathan et al., “5-HT2C receptor knockdown in the amygdala inhibits neuropathic-pain-related plasticity and behaviors,” Journal of Neuroscience, vol. 37, no. 6, pp. 1378–1393, 2017. View at Publisher · View at Google Scholar
  45. S. L. Wilcox, R. Veggeberg, J. Lemme et al., “Increased functional activation of limbic brain regions during negative emotional processing in migraine,” Frontiers in Human Neuroscience, vol. 10, p. 366, 2016. View at Publisher · View at Google Scholar
  46. L. E. Simons, I. Elman, and D. Borsook, “Psychological processing in chronic pain: a neural systems approach,” Neuroscience and Biobehavioral Reviews, vol. 39, pp. 61–78, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Qi, C. Liu, J. Ke et al., “Abnormal amygdala resting-state functional connectivity in irritable bowel syndrome,” American Journal of Neuroradiology, vol. 37, no. 6, pp. 1139–1145, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Icenhour, S. T. Witt, S. Elsenbruch et al., “Brain functional connectivity is associated with visceral sensitivity in women with irritable bowel syndrome,” NeuroImage: Clinical, vol. 15, pp. 449–457, 2017. View at Publisher · View at Google Scholar
  49. N. M. Kleinhans, C. C. Yang, E. D. Strachan, D. S. Buchwald, and K. R. Maravilla, “Alterations in connectivity on functional magnetic resonance imaging with provocation of lower urinary tract symptoms: a MAPP research network feasibility study of urological chronic pelvic pain syndromes,” Journal of Urology, vol. 195, no. 3, pp. 639–645, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Duvarci and D. Pare, “Amygdala microcircuits controlling learned fear,” Neuron, vol. 82, no. 5, pp. 966–980, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Sripanidkulchai, B. Sripanidkulchai, and J. M. Wyss, “The cortical projection of the basolateral amygdaloid nucleus in the rat: a retrograde fluorescent dye study,” Journal of Comparative Neurology, vol. 229, no. 3, pp. 419–431, 1984. View at Publisher · View at Google Scholar · View at Scopus
  52. M. H. Ossipov, K. Morimura, and F. Porreca, “Descending pain modulation and chronification of pain,” Current Opinion in Supportive and Palliative Care, vol. 8, no. 2, pp. 143–151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. T. F. Almeida, S. Roizenblatt, and S. Tufik, “Afferent pain pathways: a neuroanatomical review,” Brain Research, vol. 1000, no. 1-2, pp. 40–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. D. D. Price, “Psychological and neural mechanisms of the affective dimension of pain,” Science, vol. 288, no. 5472, pp. 1769–1772, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. F. T. Russchen and J. L. Price, “Amygdalostriatal projections in the rat. Topographical organization and fiber morphology shown using the lectin PHA-L as an anterograde tracer,” Neuroscience Letters, vol. 47, no. 1, pp. 15–22, 1984. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Wakefield and E. Hall, “Hypothalamic projections to the amygdala in the cat. A light and electron microscopic study,” Cell and Tissue Research, vol. 151, no. 4, pp. 499–508, 1974. View at Publisher · View at Google Scholar · View at Scopus
  57. D. J. Williams, A. R. Crossman, and P. Slater, “The efferent projections of the nucleus accumbens in the rat,” Brain Research, vol. 130, no. 2, pp. 217–227, 1977. View at Publisher · View at Google Scholar · View at Scopus
  58. D. S. Zahm and L. Heimer, “Specificity in the efferent projections of the nucleus accumbens in the rat: comparison of the rostral pole projection patterns with those of the core and shell,” Journal of Comparative Neurology, vol. 327, no. 2, pp. 220–232, 1993. View at Publisher · View at Google Scholar · View at Scopus
  59. D. Pare and S. Duvarci, “Amygdala microcircuits mediating fear expression and extinction,” Current Opinion in Neurobiology, vol. 22, no. 4, pp. 717–723, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Sah, E. S. L. Faber, M. Lopez De Armentia, and J. Power, “The amygdaloid complex: anatomy and physiology,” Physiological Reviews, vol. 83, no. 3, pp. 803–834, 2003. View at Publisher · View at Google Scholar
  61. J. Cheriyan, M. K. Kaushik, A. N. Ferreira, and P. L. Sheets, “Specific targeting of the basolateral amygdala to projectionally defined pyramidal neurons in prelimbic and infralimbic cortex,” eNeuro, vol. 3, no. 2, 2016. View at Publisher · View at Google Scholar
  62. P. L. A. Gabbott, T. A. Warner, and S. J. Busby, “Amygdala input monosynaptically innervates parvalbumin immunoreactive local circuit neurons in rat medial prefrontal cortex,” Neuroscience, vol. 139, no. 3, pp. 1039–1048, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. J. E. Krettek and J. L. Price, “Projections from the amygdaloid complex and adjacent olfactory structures to the entorhinal cortex and to the subiculum in the rat and cat,” Journal of Comparative Neurology, vol. 172, no. 4, pp. 723–752, 1977. View at Publisher · View at Google Scholar · View at Scopus
  64. J. E. Krettek and J. L. Price, “Projections from the amygdaloid complex to the cerebral cortex and thalamus in the rat and cat,” Journal of Comparative Neurology, vol. 172, no. 4, pp. 687–722, 1977. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Likhtik, J. G. Pelletier, A. T. Popescu, and D. Pare, “Identification of basolateral amygdala projection cells and interneurons using extracellular recordings,” Journal of Neurophysiology, vol. 96, no. 6, pp. 3257–3265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. J. P. Little and A. G. Carter, “Synaptic mechanisms underlying strong reciprocal connectivity between the medial prefrontal cortex and basolateral amygdala,” Journal of Neuroscience, vol. 33, no. 39, pp. 15333–15342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. V. Senn, S. B. E. Wolff, C. Herry et al., “Long-range connectivity defines behavioral specificity of amygdala neurons,” Neuron, vol. 81, no. 2, pp. 428–437, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. P. C. Holland and M. Gallagher, “Amygdala-frontal interactions and reward expectancy,” Current Opinion in Neurobiology, vol. 14, no. 2, pp. 148–155, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. J. L. McGaugh, “The amygdala modulates the consolidation of memories of emotionally arousing experiences,” Annual Review of Neuroscience, vol. 27, no. 1, pp. 1–28, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Tan, N. M. Lauzon, S. F. Bishop, M. A. Bechard, and S. R. Laviolette, “Integrated cannabinoid CB1 receptor transmission within the amygdala–prefrontal cortical pathway modulates neuronal plasticity and emotional memory encoding,” Cerebral Cortex, vol. 20, no. 6, pp. 1486–1496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. G. Ji, H. Sun, Y. Fu et al., “Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation,” Journal of Neuroscience, vol. 30, no. 15, pp. 5451–5464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. J. F. Bernard and J. M. Besson, “The spino(trigemino)pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes,” Journal of Neurophysiology, vol. 63, no. 3, pp. 473–490, 1990. View at Google Scholar
  73. R. Burstein and S. Potrebic, “Retrograde labeling of neurons in the spinal cord that project directly to the amygdala or the orbital cortex in the rat,” Journal of Comparative Neurology, vol. 335, no. 4, pp. 469–485, 1993. View at Publisher · View at Google Scholar · View at Scopus
  74. C.-C. Wang, W. D. Willis, and K. N. Westlund, “Ascending projections from the area around the spinal cord central canal: a Phaseolus vulgaris leucoagglutinin study in rats,” Journal of Comparative Neurology, vol. 415, no. 3, pp. 341–367, 1999. View at Publisher · View at Google Scholar
  75. A. Dobolyi, S. Irwin, G. Makara, T. B. Usdin, and M. Palkovits, “Calcitonin gene-related peptide-containing pathways in the rat forebrain,” Journal of Comparative Neurology, vol. 489, no. 1, pp. 92–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. M. C. Schiess, P. M. Callahan, and H. Zheng, “Characterization of the electrophysiological and morphological properties of rat central amygdala neurons in vitro,” Journal of Neuroscience Research, vol. 58, no. 5, pp. 663–673, 1999. View at Publisher · View at Google Scholar
  77. E. A. Harrigan, D. J. Magnuson, G. M. Thunstedt, and T. S. Gray, “Corticotropin releasing factor neurons are innervated by calcitonin gene-related peptide terminals in the rat central amygdaloid nucleus,” Brain Research Bulletin, vol. 33, no. 5, pp. 529–534, 1994. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Amano, C. T. Unal, and D. Pare, “Synaptic correlates of fear extinction in the amygdala,” Nature Neuroscience, vol. 13, no. 4, pp. 489–494, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Amir, T. Amano, and D. Pare, “Physiological identification and infralimbic responsiveness of rat intercalated amygdala neurons,” Journal of Neurophysiology, vol. 105, no. 6, pp. 3054–3066, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. C. R. Pinard, F. Mascagni, and A. J. McDonald, “Medial prefrontal cortical innervation of the intercalated nuclear region of the amygdala,” Neuroscience, vol. 205, pp. 112–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Royer, M. Martina, and D. Pare, “An inhibitory interface gates impulse traffic between the input and output stations of the amygdala,” Journal of Neuroscience, vol. 19, no. 23, pp. 10575–10583, 1999. View at Google Scholar
  82. C. Strobel, R. Marek, H. M. Gooch, R. K. Sullivan, and P. Sah, “Prefrontal and auditory input to intercalated neurons of the amygdala,” Cell Reports, vol. 10, no. 9, pp. 1435–1442, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. H. C. Pape, K. Jungling, T. Seidenbecher, J. Lesting, and R. K. Reinscheid, “Neuropeptide S: a transmitter system in the brain regulating fear and anxiety,” Neuropharmacology, vol. 58, no. 1, pp. 29–34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. R. K. Reinscheid, “Neuropeptide S: anatomy, pharmacology, genetics and physiological functions,” Results and Problems in Cell Differentiation, vol. 46, pp. 145–158, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. L. Bourgeais, C. Gauriau, and J. F. Bernard, “Projections from the nociceptive area of the central nucleus of the amygdala to the forebrain: a PHA-L study in the rat,” European Journal of Neuroscience, vol. 14, no. 2, pp. 229–255, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. A. L. Jongen-Relo and D. G. Amaral, “Evidence for a GABAergic projection from the central nucleus of the amygdala to the brainstem of the macaque monkey: a combined retrograde tracing and in situ hybridization study,” European Journal of Neuroscience, vol. 10, no. 9, pp. 2924–2933, 1998. View at Publisher · View at Google Scholar
  87. M. B. Pomrenze, E. Z. Millan, F. W. Hopf et al., “A transgenic rat for investigating the anatomy and function of corticotrophin releasing factor circuits,” Frontiers in Neuroscience, vol. 9, p. 487, 2015. View at Publisher · View at Google Scholar · View at Scopus
  88. I. Ehrlich, Y. Humeau, F. Grenier, S. Ciocchi, C. Herry, and A. Luthi, “Amygdala inhibitory circuits and the control of fear memory,” Neuron, vol. 62, no. 6, pp. 757–771, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. J. G. McCall, R. Al-Hasani, E. R. Siuda et al., “CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety,” Neuron, vol. 87, no. 3, pp. 605–620, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Ciocchi, C. Herry, F. Grenier et al., “Encoding of conditioned fear in central amygdala inhibitory circuits,” Nature, vol. 468, no. 7321, pp. 277–282, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. J. P. Fadok, S. Krabbe, M. Markovic et al., “A competitive inhibitory circuit for selection of active and passive fear responses,” Nature, vol. 542, no. 7639, pp. 96–100, 2017. View at Publisher · View at Google Scholar
  92. W. Haubensak, P. S. Kunwar, H. Cai et al., “Genetic dissection of an amygdala microcircuit that gates conditioned fear,” Nature, vol. 468, no. 7321, pp. 270–276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. G. Ji, C. Horvath, and V. Neugebauer, “NR2B receptor blockade inhibits pain-related sensitization of amygdala neurons,” Molecular Pain, vol. 5, p. 21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. G. Ji and V. Neugebauer, “Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala,” Journal of Neurophysiology, vol. 97, no. 6, pp. 3893–3904, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. W. Li and V. Neugebauer, “Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons,” Journal of Neurophysiology, vol. 91, no. 1, pp. 13–24, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. W. Li and V. Neugebauer, “Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain,” Journal of Neurophysiology, vol. 96, no. 4, pp. 1803–1815, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. W. Li and V. Neugebauer, “Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain,” Pain, vol. 110, no. 1, pp. 112–122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. T. Nakagawa, A. Katsuya, S. Tanimoto et al., “Differential patterns of c-fos mRNA expression in the amygdaloid nuclei induced by chemical somatic and visceral noxious stimuli in rats,” Neuroscience Letters, vol. 344, no. 3, pp. 197–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Nakao, Y. Takahashi, M. Nagase, R. Ikeda, and F. Kato, “Role of capsaicin-sensitive C-fiber afferents in neuropathic pain-induced synaptic potentiation in the nociceptive amygdala,” Molecular Pain, vol. 8, p. 51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. T. Rouwette, P. Vanelderen, M. de Reus et al., “Experimental neuropathy increases limbic forebrain CRF,” European Journal of Pain, vol. 16, no. 1, pp. 61–71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. Y. M. Ulrich-Lai, W. Xie, J. T. Meij, C. M. Dolgas, L. Yu, and J. P. Herman, “Limbic and HPA axis function in an animal model of chronic neuropathic pain,” Physiology and Behavior, vol. 88, no. 1-2, pp. 67–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. B. J. Kolber, M. C. Montana, Y. Carrasquillo et al., “Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior,” Journal of Neuroscience, vol. 30, no. 24, pp. 8203–8213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. G. Ji and V. Neugebauer, “Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors,” Journal of Neurophysiology, vol. 99, no. 3, pp. 1201–1212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. Fu, J. Han, T. Ishola et al., “PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior,” Molecular Pain, vol. 4, p. 26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. Z. Li, G. Ji, and V. Neugebauer, “Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior,” Journal of Neuroscience, vol. 31, no. 3, pp. 1114–1127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. B. Bonaz, M. Baciu, E. Papillon et al., “Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study,” American Journal of Gastroenterology, vol. 97, no. 3, pp. 654–661, 2002. View at Publisher · View at Google Scholar
  107. P. J. Whalen, S. L. Rauch, N. L. Etcoff, S. C. McInerney, M. B. Lee, and M. A. Jenike, “Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge,” Journal of Neuroscience, vol. 18, no. 1, pp. 411–418, 1998. View at Google Scholar
  108. S. L. Rauch, P. J. Whalen, L. M. Shin et al., “Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study,” Biological Psychiatry, vol. 47, no. 9, pp. 769–776, 2000. View at Publisher · View at Google Scholar · View at Scopus
  109. L. Cahill, R. J. Haier, N. S. White et al., “Sex-related difference in amygdala activity during emotionally influenced memory storage,” Neurobiology of Learning and Memory, vol. 75, no. 1, pp. 1–9, 2001. View at Publisher · View at Google Scholar · View at Scopus
  110. L. Cahill, M. Uncapher, L. Kilpatrick, M. T. Alkire, and J. Turner, “Sex-related hemispheric lateralization of amygdala function in emotionally influenced memory: an fMRI investigation,” Learning and Memory, vol. 11, no. 3, pp. 261–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  111. E. Likhtik, D. Popa, J. Apergis-Schoute, G. A. Fidacaro, and D. Pare, “Amygdala intercalated neurons are required for expression of fear extinction,” Nature, vol. 454, no. 7204, pp. 642–645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. S. G. Woodhams, V. Chapman, D. P. Finn, A. G. Hohmann, and V. Neugebauer, “The cannabinoid system and pain,” Neuropharmacology, vol. 124, pp. 105–120, 2017. View at Publisher · View at Google Scholar
  113. C. H. Chang and S. Maren, “Strain difference in the effect of infralimbic cortex lesions on fear extinction in rats,” Behavioral Neuroscience, vol. 124, no. 3, pp. 391–397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. K. Hefner, N. Whittle, J. Juhasz et al., “Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain,” Journal of Neuroscience, vol. 28, no. 32, pp. 8074–8085, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. S. C. Kim, Y. S. Jo, I. H. Kim, H. Kim, and J.-S. Choi, “Lack of medial prefrontal cortex activation underlies the immediate extinction deficit,” Journal of Neuroscience, vol. 30, no. 3, pp. 832–837, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. D. Sierra-Mercado, N. Padilla-Coreano, and G. J. Quirk, “Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear,” Neuropsychopharmacology, vol. 36, no. 2, pp. 529–538, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. A. V. Apkarian, Y. Sosa, S. Sonty et al., “Chronic back pain is associated with decreased prefrontal and thalamic gray matter density,” Journal of Neuroscience, vol. 24, no. 46, pp. 10410–10415, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. E. A. Mayer, S. Berman, B. Suyenobu et al., “Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis,” Pain, vol. 115, no. 3, pp. 398–409, 2005. View at Publisher · View at Google Scholar · View at Scopus
  119. H. Cardoso-Cruz, M. Sousa, J. B. Vieira, D. Lima, and V. Galhardo, “Prefrontal cortex and mediodorsal thalamus reduced connectivity is associated with spatial working memory impairment in rats with inflammatory pain,” Pain, vol. 154, no. 11, pp. 2397–2406, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. C. J. Kelly, M. Huang, H. Meltzer, and M. Martina, “Reduced glutamatergic currents and dendritic branching of layer 5 pyramidal cells contribute to medial prefrontal cortex deactivation in a rat model of neuropathic pain,” Frontiers in Cellular Neuroscience, vol. 10, p. 133, 2016. View at Publisher · View at Google Scholar · View at Scopus
  121. A. E. Metz, H.-J. Yau, M. V. Centeno, A. V. Apkarian, and M. Martina, “Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain,” Proceedings of the National Academy of Sciences, vol. 106, no. 7, pp. 2423–2428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. G. Ji and V. Neugebauer, “Pain-related deactivation of medial prefrontal cortical neurons involves mGluR1 and GABAA receptors,” Journal of Neurophysiology, vol. 106, no. 5, pp. 2642–2652, 2011. View at Publisher · View at Google Scholar · View at Scopus
  123. G. Ji and V. Neugebauer, “CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model,” European Journal of Neuroscience, vol. 39, no. 3, pp. 455–466, 2014. View at Publisher · View at Google Scholar · View at Scopus
  124. G. Q. Wang, C. Cen, C. Li et al., “Deactivation of excitatory neurons in the prelimbic cortex via Cdk5 promotes pain sensation and anxiety,” Nature Communications, vol. 6, p. 7660, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. Z. Zhang, V. M. Gadotti, L. Chen, I. A. Souza, P. L. Stemkowski, and G. W. Zamponi, “Role of prelimbic GABAergic circuits in sensory and emotional aspects of neuropathic pain,” Cell Reports, vol. 12, no. 5, pp. 752–759, 2015. View at Publisher · View at Google Scholar · View at Scopus
  126. T. Kiritoshi, G. Ji, and V. Neugebauer, “Rescue of impaired mGluR5-driven endocannabinoid signaling restores prefrontal cortical output to inhibit pain in arthritic rats,” Journal of Neuroscience, vol. 36, no. 3, pp. 837–850, 2016. View at Publisher · View at Google Scholar · View at Scopus
  127. L. M. McGarry and A. G. Carter, “Inhibitory gating of basolateral amygdala inputs to the prefrontal cortex,” Journal of Neuroscience, vol. 36, no. 36, pp. 9391–9406, 2016. View at Publisher · View at Google Scholar · View at Scopus
  128. H. Sun and V. Neugebauer, “mGluR1, but not mGluR5, activates feed-forward inhibition in the medial prefrontal cortex to impair decision making,” Journal of Neurophysiology, vol. 106, no. 2, pp. 960–973, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. E. C. Muly, M. Maddox, and Y. Smith, “Distribution of mGluR1α and mGluR5 immunolabeling in primate prefrontal cortex,” Journal of Comparative Neurology, vol. 467, no. 4, pp. 521–535, 2003. View at Publisher · View at Google Scholar · View at Scopus
  130. D. E. Fontanez-Nuin, E. Santini, G. J. Quirk, and J. T. Porter, “Memory for fear extinction requires mGluR5-mediated activation of infralimbic neurons,” Cerebral Cortex, vol. 21, no. 3, pp. 727–735, 2011. View at Publisher · View at Google Scholar · View at Scopus
  131. T. Kiritoshi, H. Sun, W. Ren et al., “Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1,” Neuropharmacology, vol. 66, pp. 170–178, 2013. View at Publisher · View at Google Scholar · View at Scopus
  132. G. J. Marek and C. Zhang, “Activation of metabotropic glutamate 5 (mGlu5) receptors induces spontaneous excitatory synaptic currents in layer V pyramidal cells of the rat prefrontal cortex,” Neuroscience Letters, vol. 442, no. 3, pp. 239–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  133. M. Lafourcade, I. Elezgarai, S. Mato, Y. Bakiri, P. Grandes, and O. J. Manzoni, “Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex,” PLoS One, vol. 2, no. 8, p. e709, 2007. View at Publisher · View at Google Scholar · View at Scopus
  134. J. S. Han, H. Adwanikar, Z. Li, G. Ji, and V. Neugebauer, “Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats,” Molecular Pain, vol. 6, p. 10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  135. G. Ji, Y. Fu, H. Adwanikar, and V. Neugebauer, “Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses,” Molecular Pain, vol. 9, p. 2, 2013. View at Publisher · View at Google Scholar · View at Scopus
  136. T. Kiritoshi and V. Neugebauer, “Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex,” Neuropharmacology, vol. 95, pp. 388–394, 2015. View at Publisher · View at Google Scholar · View at Scopus
  137. K. Jungling, T. Seidenbecher, L. Sosulina et al., “Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala,” Neuron, vol. 59, no. 2, pp. 298–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  138. S. K. Leonard and R. H. Ring, “Immunohistochemical localization of the neuropeptide S receptor in the rat central nervous system,” Neuroscience, vol. 172, pp. 153–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  139. A. Pulga, C. Ruzza, A. Rizzi, R. Guerrini, and G. Calo, “Anxiolytic- and panicolytic-like effects of neuropeptide S in the mouse elevated T-maze,” European Journal of Neuroscience, vol. 36, no. 11, pp. 3531–3537, 2012. View at Publisher · View at Google Scholar · View at Scopus
  140. C. Ruzza, A. Rizzi, V. Camarda et al., “[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies,” Peptides, vol. 34, no. 2, pp. 404–411, 2012. View at Publisher · View at Google Scholar · View at Scopus
  141. Y. L. Xu, C. M. Gall, V. R. Jackson, O. Civelli, and R. K. Reinscheid, “Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain,” Journal of Comparative Neurology, vol. 500, no. 1, pp. 84–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  142. G. Medina, G. Ji, S. Gregoire, and V. Neugebauer, “Nasal application of neuropeptide S inhibits arthritis pain-related behaviors through an action in the amygdala,” Molecular Pain, vol. 10, p. 32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  143. E. Vachon-Presseau, P. Tetreault, B. Petre et al., “Corticolimbic anatomical characteristics predetermine risk for chronic pain,” Brain, vol. 139, no. 7, pp. 1958–1970, 2016. View at Publisher · View at Google Scholar · View at Scopus
  144. P. Mason, “Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions,” Annual Review of Neuroscience, vol. 24, no. 1, pp. 737–777, 2001. View at Publisher · View at Google Scholar · View at Scopus
  145. R. Staud, “The important role of CNS facilitation and inhibition for chronic pain,” International Journal of Clinical Rheumatology, vol. 8, no. 6, pp. 639–646, 2013. View at Publisher · View at Google Scholar · View at Scopus
  146. R. H. Dworkin, A. B. O’Connor, J. Audette et al., “Recommendations for the pharmacological management of neuropathic pain: an overview and literature update,” Mayo Clinic Proceedings, vol. 85, no. 3, pp. S3–S14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. N. B. Finnerup, N. Attal, S. Haroutounian et al., “Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis,” Lancet Neurology, vol. 14, no. 2, pp. 162–173, 2015. View at Publisher · View at Google Scholar · View at Scopus
  148. Y. C. Lee and P. P. Chen, “A review of SSRIs and SNRIs in neuropathic pain,” Expert Opinion on Pharmacotherapy, vol. 11, no. 17, pp. 2813–2825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  149. C. Brasch-Andersen, M. U. Moller, L. Christiansen et al., “A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C),” European Journal of Clinical Pharmacology, vol. 67, no. 11, pp. 1131–1137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  150. N. H. Jensen, T. I. Cremers, and F. Sotty, “Therapeutic potential of 5-HT2C receptor ligands,” Scientific World Journal, vol. 10, pp. 1870–1885, 2010. View at Publisher · View at Google Scholar · View at Scopus
  151. B. M. Campbell and K. M. Merchant, “Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment,” Brain Research, vol. 993, no. 1-2, pp. 1–9, 2003. View at Publisher · View at Google Scholar · View at Scopus
  152. J. P. Christianson, T. Ragole, J. Amat et al., “5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress,” Biological Psychiatry, vol. 67, no. 4, pp. 339–345, 2010. View at Publisher · View at Google Scholar · View at Scopus
  153. L. K. Heisler, L. Zhou, P. Bajwa, J. Hsu, and L. H. Tecott, “Serotonin 5-HT2C receptors regulate anxiety-like behavior,” Genes, Brain and Behavior, vol. 6, no. 5, pp. 491–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  154. S. Gregoire and V. Neugebauer, “5-HT2CR blockade in the amygdala conveys analgesic efficacy to SSRIs in a rat model of arthritis pain,” Molecular Pain, vol. 9, p. 41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  155. J. P. Adelman, J. Maylie, and P. Sah, “Small-conductance Ca2+-activated K+ channels: form and function,” Annual Review of Physiology, vol. 74, no. 1, pp. 245–269, 2012. View at Publisher · View at Google Scholar · View at Scopus
  156. M. Gymnopoulos, L. A. Cingolani, P. Pedarzani, and M. Stocker, “Developmental mapping of small-conductance calcium-activated potassium channel expression in the rat nervous system,” Journal of Comparative Neurology, vol. 522, no. 5, pp. 1072–1101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  157. M. Kohler, B. Hirschberg, C. T. Bond et al., “Small-conductance, calcium-activated potassium channels from mammalian brain,” Science, vol. 273, no. 5282, pp. 1709–1714, 1996. View at Publisher · View at Google Scholar
  158. M. Stocker, “Ca2+-activated K+ channels: molecular determinants and function of the SK family,” Nature Reviews Neuroscience, vol. 5, no. 10, pp. 758–770, 2004. View at Publisher · View at Google Scholar · View at Scopus
  159. M. Lopez de Armentia and P. Sah, “Firing properties and connectivity of neurons in the rat lateral central nucleus of the amygdala,” Journal of Neurophysiology, vol. 92, no. 3, pp. 1285–1294, 2004. View at Publisher · View at Google Scholar · View at Scopus
  160. E. S. L. Faber and P. Sah, “Functions of SK channels in central neurons,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 10, pp. 1077–1083, 2007. View at Publisher · View at Google Scholar · View at Scopus
  161. E. S. Faber, A. J. Delaney, and P. Sah, “SK channels regulate excitatory synaptic transmission and plasticity in the lateral amygdala,” Nature Neuroscience, vol. 8, no. 5, pp. 635–641, 2005. View at Publisher · View at Google Scholar · View at Scopus
  162. E. S. Faber, A. J. Delaney, J. M. Power, P. L. Sedlak, J. W. Crane, and P. Sah, “Modulation of SK channel trafficking by beta adrenoceptors enhances excitatory synaptic transmission and plasticity in the amygdala,” Journal of Neuroscience, vol. 28, no. 43, pp. 10803–10813, 2008. View at Publisher · View at Google Scholar · View at Scopus
  163. Y. J. Cao, J. C. Dreixler, J. J. Couey, and K. M. Houamed, “Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole,” European Journal of Pharmacology, vol. 449, no. 1-2, pp. 47–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  164. J. Wokke, “Riluzole,” Lancet, vol. 348, no. 9030, pp. 795–799, 1996. View at Publisher · View at Google Scholar · View at Scopus
  165. M. C. Bellingham, “A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?” CNS Neuroscience and Therapeutics, vol. 17, no. 1, pp. 4–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  166. A. Doble, “The pharmacology and mechanism of action of riluzole,” Neurology, vol. 47, no. 6, pp. S233–S241, 1996. View at Publisher · View at Google Scholar
  167. S.-J. Wang, K.-Y. Wang, and W.-C. Wang, “Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes),” Neuroscience, vol. 125, no. 1, pp. 191–201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  168. G. Blackburn-Munro, N. Ibsen, and H. K. Erichsen, “A comparison of the anti-nociceptive effects of voltage-activated Na+ channel blockers in the formalin test,” European Journal of Pharmacology, vol. 445, no. 3, pp. 231–238, 2002. View at Publisher · View at Google Scholar · View at Scopus
  169. T. J. Coderre, N. Kumar, C. D. Lefebvre, and J. S. C. Yu, “A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain,” Journal of Neurochemistry, vol. 100, no. 5, pp. 1289–1299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  170. G. Munro, H. K. Erichsen, and N. R. Mirza, “Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety,” Neuropharmacology, vol. 53, no. 5, pp. 609–618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  171. C. Abarca, E. Silva, M. J. Sepulveda, P. Oliva, and E. Contreras, “Neurochemical changes after morphine, dizocilpine or riluzole in the ventral posterolateral thalamic nuclei of rats with hyperalgesia,” European Journal of Pharmacology, vol. 403, no. 1-2, pp. 67–74, 2000. View at Publisher · View at Google Scholar · View at Scopus
  172. D. J. Chew, T. Carlstedt, and P. J. Shortland, “The effects of minocycline or riluzole treatment on spinal root avulsion–induced pain in adult rats,” Journal of Pain, vol. 15, no. 6, pp. 664–675, 2014. View at Publisher · View at Google Scholar · View at Scopus
  173. A. Hama and J. Sagen, “Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain,” Journal of Neurotrauma, vol. 28, no. 1, pp. 127–134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  174. E. S. Moon, S. K. Karadimas, W.-R. Yu, J. W. Austin, and M. G. Fehlings, “Riluzole attenuates neuropathic pain and enhances functional recovery in a rodent model of cervical spondylotic myelopathy,” Neurobiology of Disease, vol. 62, pp. 394–406, 2014. View at Publisher · View at Google Scholar · View at Scopus
  175. B. Sung, G. Lim, and J. Mao, “Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats,” Journal of Neuroscience, vol. 23, no. 7, pp. 2899–2910, 2003. View at Google Scholar
  176. S. P. Mishra, S. K. Shukla, and B. L. Pandey, “A preliminary evaluation of comparative effectiveness of riluzole in therapeutic regimen for irritable bowel syndrome,” Asian Pacific Journal of Tropical Biomedicine, vol. 4, pp. S335–S340, 2014. View at Publisher · View at Google Scholar · View at Scopus
  177. J. M. Thompson, G. Ji, and V. Neugebauer, “Small-conductance calcium-activated potassium (SK) channels in the amygdala mediate pain-inhibiting effects of clinically available riluzole in a rat model of arthritis pain,” Molecular Pain, vol. 11, p. 51, 2015. View at Publisher · View at Google Scholar · View at Scopus
  178. J. S. Han and V. Neugebauer, “mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain,” Pain, vol. 113, no. 1, pp. 211–222, 2005. View at Publisher · View at Google Scholar · View at Scopus